DRG International, Inc.

DRG International, Inc. develops, manufactures and distributes ELISA test kits for clinical and research applications worldwide. DRG also supplies clinical laboratory equipment to complete the diagnostic reagent product line. In addition to a wide range of ELISA kits for endocrinology, diabetes, infectious diseases and tumor markers for diagnostic / R& D purposes, DRG is pleased to introduce its newest Prenatal Supervision kits: PLGF ELISA (new marker for Preeclampsia) and PAPP-A ELISA, as well as the new DRG PKU Neonatal Screening Assay Kit. DRG also offers Iron Metabolism products particularly the Hepcidin Prohormone and the Hepcidin (human) ELISA kit (U. S. Patents 7, 320, 894 and 7, 411, 048) to be released early by 2009. DRG International, Inc. , founded in 1970 is a multinational specialty medical equipment and diagnostics manufacturer and distributor with successful representation in over 100 countries through a network of DRG Subsidiaries and local distributors. The highly skilled DRG Staff of medical, clinical, marketing and service specialists are experienced in supplying cost effective innovative products and systems to our customers Worldwide. Located 18 miles West of New York City, DRG Corporate Headquarters provides logistic and financial management support to DRG Subsidiaries overseas and coordinates the DRG distributor network. An experienced, multinational, multilingual staff is ready to serve your medical and diagnostic products needs Worldwide. NOTE: DRG is a Registered Trademark of DRG International, Inc.